Literature DB >> 19017948

Drak2 regulates the survival of activated T cells and is required for organ-specific autoimmune disease.

Maureen A McGargill1, Carmen Choy, Ben G Wen, Stephen M Hedrick.   

Abstract

Drak2 is a serine/threonine kinase expressed in T and B cells. The absence of Drak2 renders T cells hypersensitive to suboptimal stimulation, yet Drak2(-/-) mice are enigmatically resistant to experimental autoimmune encephalomyelitis, an animal model of multiple sclerosis. We show in this study that Drak2(-/-) mice were also completely resistant to type 1 diabetes when bred to the NOD strain of mice that spontaneously develop autoimmune diabetes. However, there was not a generalized suppression of the immune system, because Drak2(-/-) mice remained susceptible to other models of autoimmunity. Adoptive transfer experiments revealed that resistance to disease was intrinsic to the T cells and was due to a loss of T cell survival under conditions of chronic autoimmune stimulation. Importantly, the absence of Drak2 did not alter the survival of naive T cells, memory T cells, or T cells responding to an acute viral infection. These experiments reveal a distinction between the immune response to persistent self-encoded molecules and transiently present infectious agents. We present a model whereby T cell survival depends on a balance of TCR and costimulatory signals to explain how the absence of Drak2 affects autoimmune disease without generalized suppression of the immune system.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19017948      PMCID: PMC2792703          DOI: 10.4049/jimmunol.181.11.7593

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  67 in total

1.  The effect of apoptosis inhibitors on experimental autoimmune encephalomyelitis: apoptosis as a regulatory factor.

Authors:  Y Okuda; S Sakoda; H Fujimura; T Yanagihara
Journal:  Biochem Biophys Res Commun       Date:  2000-01-27       Impact factor: 3.575

Review 2.  Negative regulation of T cell receptor signals.

Authors:  Manu Rangachari; Josef M Penninger
Journal:  Curr Opin Pharmacol       Date:  2004-08       Impact factor: 5.547

3.  Cutting edge: critical role for CD5 in experimental autoimmune encephalomyelitis: inhibition of engagement reverses disease in mice.

Authors:  Robert C Axtell; Matthew S Webb; Scott R Barnum; Chander Raman
Journal:  J Immunol       Date:  2004-09-01       Impact factor: 5.422

4.  Modulation of Th1 activation and inflammation by the NF-kappaB repressor Foxj1.

Authors:  Ling Lin; Melanie S Spoor; Andrea J Gerth; Steven L Brody; Stanford L Peng
Journal:  Science       Date:  2004-02-13       Impact factor: 47.728

5.  Cbl-b regulates the CD28 dependence of T-cell activation.

Authors:  Y J Chiang; H K Kole; K Brown; M Naramura; S Fukuhara; R J Hu; I K Jang; J S Gutkind; E Shevach; H Gu
Journal:  Nature       Date:  2000-01-13       Impact factor: 49.962

6.  Negative regulation of lymphocyte activation and autoimmunity by the molecular adaptor Cbl-b.

Authors:  K Bachmaier; C Krawczyk; I Kozieradzki; Y Y Kong; T Sasaki; A Oliveira-dos-Santos; S Mariathasan; D Bouchard; A Wakeham; A Itie; J Le; P S Ohashi; I Sarosi; H Nishina; S Lipkowitz; J M Penninger
Journal:  Nature       Date:  2000-01-13       Impact factor: 49.962

7.  Anti-CD3 antibody induces long-term remission of overt autoimmunity in nonobese diabetic mice.

Authors:  L Chatenoud; E Thervet; J Primo; J F Bach
Journal:  Proc Natl Acad Sci U S A       Date:  1994-01-04       Impact factor: 11.205

8.  Non-obese diabetic (NOD) mice display enhanced immune responses and prolonged survival of lymphoid cells.

Authors:  K Leijon; B Hammarström; D Holmberg
Journal:  Int Immunol       Date:  1994-02       Impact factor: 4.823

9.  Mast cells are essential for early onset and severe disease in a murine model of multiple sclerosis.

Authors:  V H Secor; W E Secor; C A Gutekunst; M A Brown
Journal:  J Exp Med       Date:  2000-03-06       Impact factor: 14.307

10.  Expression and catalytic activity of the tyrosine phosphatase PTP1C is severely impaired in motheaten and viable motheaten mice.

Authors:  M Kozlowski; I Mlinaric-Rascan; G S Feng; R Shen; T Pawson; K A Siminovitch
Journal:  J Exp Med       Date:  1993-12-01       Impact factor: 14.307

View more
  9 in total

1.  Drak2 is not required for tumor surveillance and suppression.

Authors:  Benjamin A Edwards; Tarsha L Harris; Helen Floersh; John R Lukens; Md Hasan Zaki; Peter Vogel; Thirumala-Devi Kanneganti; Jack D Bui; Maureen A McGargill
Journal:  Int Immunol       Date:  2015-01-07       Impact factor: 4.823

2.  Protein kinase D orchestrates the activation of DRAK2 in response to TCR-induced Ca2+ influx and mitochondrial reactive oxygen generation.

Authors:  Ryan H Newton; Sabrina Leverrier; Sonal Srikanth; Yousang Gwack; Michael D Cahalan; Craig M Walsh
Journal:  J Immunol       Date:  2010-12-10       Impact factor: 5.422

3.  Loss of DRAK2 signaling enhances allogeneic transplant survival by limiting effector and memory T cell responses.

Authors:  B M Weist; J B Hernandez; C M Walsh
Journal:  Am J Transplant       Date:  2012-04-11       Impact factor: 8.086

4.  Polar opposites: Erk direction of CD4 T cell subsets.

Authors:  Chiung-Fang Chang; Warren N D'Souza; Irene L Ch'en; Gilles Pages; Jacques Pouyssegur; Stephen M Hedrick
Journal:  J Immunol       Date:  2012-06-06       Impact factor: 5.422

5.  A Chemical Probe for Dark Kinase STK17B Derives Its Potency and High Selectivity through a Unique P-Loop Conformation.

Authors:  Alfredo Picado; Apirat Chaikuad; Carrow I Wells; Safal Shrestha; William J Zuercher; Julie E Pickett; Frank E Kwarcinski; Parvathi Sinha; Chandi S de Silva; Reena Zutshi; Shubin Liu; Natarajan Kannan; Stefan Knapp; David H Drewry; Timothy M Willson
Journal:  J Med Chem       Date:  2020-11-20       Impact factor: 7.446

6.  Regulation of the apoptosis-inducing kinase DRAK2 by cyclooxygenase-2 in colorectal cancer.

Authors:  G A Doherty; S M Byrne; S C Austin; G M Scully; D M Sadlier; T G Neilan; E W Kay; F E Murray; D J Fitzgerald
Journal:  Br J Cancer       Date:  2009-08-04       Impact factor: 7.640

7.  Drak2 Does Not Regulate TGF-β Signaling in T Cells.

Authors:  Tarsha L Harris; Maureen A McGargill
Journal:  PLoS One       Date:  2015-05-07       Impact factor: 3.240

8.  Prognostic and immune-related value of STK17B in skin cutaneous melanoma.

Authors:  Xueying Shi; Qi Zhou; Bingqian Huang; Shilin Xia; Yuankuan Jiang; Shifeng Fang; Jingrong Lin
Journal:  PLoS One       Date:  2022-02-16       Impact factor: 3.240

Review 9.  Modulation of T Cell Metabolism and Function through Calcium Signaling.

Authors:  Kelley M Fracchia; Christine Y Pai; Craig M Walsh
Journal:  Front Immunol       Date:  2013-10-11       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.